Infectivity of human herpesvirus 6 (HHV-6) was physicochemically characterized. Virus particles were excreted from infected cord blood mononuclear cells into the culture supernatant at a concentration of 108 to 109 virus particles/ml. The virus particle/infectivity ratio of HHV-6 in the culture supernatant was approximately 103"1 and that in the sonicated infected cells was 104: 1. Infectivity was stable below 37 °C and at neutral pH (7.0 to 8.5). These fundamental data may be useful for serological and biological research on HHV-6.
A new member of the human herpesvirus group (Salahuddin et al., 1986) , human herpesvirus 6 (IdHV-6) is a CD4-T lymphotropic virus (Lusso et al., 1988; Takahashi et al., 1989) and found to be an aetiological agent of exanthem subitum (Yamanishi et al., 1988) . HHV-6 is associated with lymphadenopathy (Eizuru et al., 1989) and reactivated in immunosuppressed renal transplant recipients (Okuno et al., 1990a) . Studies on HHV-6 have identified virion proteins and viral glycoproteins (Balachandran et al., 1989; Shiraki et al., 1989 a; Okuno et al., 1990b) , and HHV-6-specific DNA polymerase in HHV-6-infected cells (Bapat et al., 1989; Shiraki et al., 1989b) . The biological nature of HHV-6 however, has not been studied because of the highly cellassociated nature of infectivity (Lopez et al., 1988) . Efstathiou et al. (1988) and Lawrence et al. (1990) reported the close genetic relationship between HHV-6 and human cytomegalovirus (HCMV), which might reflect biological properties similar between these two human herpesviruses. We have developed a serological assay system by using cell-free virus (Asada et al., 1989) . This study was designed to characterize the physicochemical nature of HHV-6 infectivity on which to base serological and virological research.
Mononuclear cells were separated from cord blood by centrifugation on a Ficoll-Paque gradient and grown in RPMI 1640 supplemented with 10~o foetal bovine serum (FBS), 5 gg/ml of phytohaemagglutinin (PHA; Honen Oil Company) and 0.1 unit/ml of recombinant human interleukin-2 (Takeda Chemical Industries). The HHV-6 used was the HST strain (Shiraki et al., 1989a, b; Yamanishi et al., 1988) . After infection the cells were 1" Present address: Department of Virology, Toyama Medical and Pharmaceutical University, Sugitani, Toyama 930-01, Japan. incubated in RPMI 1640 supplemented with 109/o FBS and 5 l.tg/ml PHA. Extracellular cell-free virus was prepared from the culture supernatant of the HHV-6-infected mononuclear cell culture. When 50 to 70~ of cells showed cytopathic effects, the culture supernatant was centrifuged at 3000 r.p.m, for 10 min and frozen at -70 °C as extracellular cell-free virus until use. Cell-free virions of HHV-6 were prepared from infected mononuclear cells (Shiraki et al., 1989b) . Briefly, infected cells were harvested by centrifugation and sonicated in phosphate-buffered saline (PBS) containing 10~ FBS, 0.1 ~ sodium glutamate and 5 ~o sucrose. After centrifugation the supernatant was stored at -70°C as intracellular cell-free virus until use.
Virus particles were counted by the procedure (the loop drop method) reported by Watson et al. (1963) and Shiraki & Takahashi (1982) . Briefly, virus solution was mixed with a standard latex particle solution (109 nm in diameter; Dow Chemical Company) and the mixture was placed on a grid and stained with 1 ~o neutral phosphotungstate. The number of virus and latex particles was counted under the electron microscope and the number of virus particles was determined by comparison with that of the latex particles in the standard solution. The virus particles were divided morphologically into enveloped and naked virus particles. HHV-6 infectivity was determined by infection of cell-free virus to MT-4 cells. An aliquot of serially diluted virus solution was inoculated into MT-4 cells on a glass slide (Asada et al., 1989) or in microplates by centrifugation at 3000 r.p.m, for 1 h (Pietroboni et al., 1989) . The number of infected cells was determined by the immunofluorescent antibody test with monoclonal antibody 40 h after infection (Asada et al., 1989; Okuno et al., 1990b) . 0000-9797 © 1991 SGM Table 3 .
Effect of pH on HHV-6 infectivity
Temperature pH 0 °C 37 °C 6"0 13"3 + 16"4" 24'6 + 6"3 6"5 72"0 + 0'7 67"0 + 40"0 7'0 100'6 ___ 18"6 92"I + 1"7 7"5 100-8 + 13"1 112"5 + 23"9 8"0 121-0 + 13"5 104'1 _+ 7'4 8"5 98-7 + 20-8 91"2 +_ 4"8 * The residual infectivity was evaluated as the percentage of the infectivity of the same virus stock solution kept at -70 °C and expressed as the mean + standard deviation of three independent experiments. Ceil-free virus from the culture supernatant was used to assay the sensitivity of viral infectivity to temperature and pH. The virus solution was adjusted to pH 7.5 and incubated at 0 °C, 4 °C, 25 °C, 37 °C, 42 °C and 50 °C for 1 h. Then their residual infectivities were compared and expressed as the percentage of infectivity of the same virus stock. The virus solution was adjusted to pH 6-0, 6.5, 7.0, 7-5, 8.0 and 8.5 with PBS and incubated at 0 °C and 37 °C for 1 h. The residual infectivity was then determined.
The result of virus titration by the glass slide method and centrifugal infection was similar. The correlation between infectivity and virus particles in cell-free virus preparations is shown in Table 1 . Virus particles were divided into two categories, enveloped and naked, as shown in Fig. 1 . The number of virus particles in the culture supernatant ranged from 4 x 108 to 3 × 109 per ml, and the number in the sonicated infected cells was 5 x 109 to 8 × 109 per ml. A similar number of enveloped and naked virus particles was observed and no significant morphological differences were noted in either preparation method. Virus particles per infectivity ratio ranged from 9.23 x l02 to 8-44 x 103 in the culture supernatants and from 1.18 x 104 to 4-85 × l04 in the sonicated infected cells.
The temperature sensitivity of HHV-6 infectivity is shown in Table 2 . HHV-6 infectivity was stable below 37 °C and unstable above 42 °C. Infectivity was stable in neutral pH (7.0 to 8.5) at both 0 °C and 37 °C but unstable below pH 6-5 as shown in Table 3 .
This study clarified the physicochemical character of the infectivity of HHV-6 and showed that HHV-6 is stable at physiological temperature and pH. The number of virus particles excreted into HHV-6 infected cell culture supernatant was similar to that excreted in varicella-zoster virus (VZV)-infected cell culture supernatant, but the infectivity of HHV-6 was retained in the supernatant in contrast to VZV (Shiraki & Takahashi, 1982) . The number of virus particles of HHV-6 observed was similar to that of herpes simplex virus (HSV) (Smith, 1964; Watson et al., 1963; Shiraki & Takahashi, 1982) , HCMV and Epstein-Barr virus (Yamaguchi, 1969) . The virus particle/infectivity ratio of HHV-6 was approximately 103 : 1 and those of VZV, HSV and HCMV were approximately 106:1 (Shiraki & Takahashi, 1982) , 10 to 80:1 (Smith, 1964; Watson et al., 1963; Shiraki & Takahashi, 1982) and 160 to 1050:1 , respectively.
The HST strain has been passaged in vitro (Yamanishi et al., 1988) and grows better than other HHV-6 isolates. Certain strains of HHV-6 grow well in certain cell lines and significant amounts of cell-free virus have been produced (Ablashi et al., 1987; Okuno et al., 1989; Shiraki et al., 1989a, b) . The stability of infectivity is much influenced by the particular preparation and buffers used to contain celt-free virus (Asano & Takahashi, 1978; Farnham & Newton, 1959; Vonka & BenyeshMelnick, 1966; Wentworth & Gloyd, 1968; Hoggan & Roizman, 1959 ) and therefore the virus particle/infectivity ratio of HHV-6 will be much improved when appropriate conditions for the preparation of cell-free virus are achieved. The virus particle/infectivity ratio of the sonicated infected cells was higher than that of the culture supernatants, but this would not necessarily imply a low efficiency of infectivity of cell-free virus in sonicated infected cells. Because the cell-free virus was prepared from cells infected with HHV-6 which were cultured for a few days after infection, these cultures might have contained many inactivated viruses in dead infected cells, which might have increased the number of viral particles. HHV-6 infectivity was not as cellassociated as reported (Lopez et al., 1988) , but it is not clear that the relatively high infectivity and stability of HHV-6 was caused by differences between strains or the culture conditions used.
HHV-6 infectivity was stable at physiological temperature and neutral pH as shown in Tables 2 and 3 and the thermal stability of HHV-6 was similar to those of HSV (Kaplan, 1957; Hoggan & Roizman, 1959) and HCMV (Wentworth & Gloyd, 1968) but different from those of HSV (Farnham & Newton, 1959) and HCMV (Vonka & Benyesh-Melnick, 1966) . However, because the stability of the virus is influenced by the constituents of the diluent or storing buffers (Asano & Takahashi, 1978; Farnham & Newton, 1959; Vonka & BenyeshMelnick, 1966; Wentworth & Gloyd, 1968; Hoggan & Roizman, 1959) , it is difficult to compare results on the thermal stability of viruses. The infectivity of HHV-6 was stable at pH values higher than 7.0 but was inactivated below pH 6.5 and the standard deviation of residual infectivity of three experiments at pH 6.5 at 37 °C was large compared with the others, which suggested that this pH might be the critical point for the inactivation of HHV-6. The stability of HHV-6 was similar to that of HSV (Farnham & Newton, 1959) .
This study concerned the physicochemical character of HHV-6 infectivity and these fundamental data may be useful for serological and biological research on HHV-6.
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